HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fatal cerebral haemorrhage after liver transplantation in a patient with transthyretin variant (gly53glu) amyloidosis.

Abstract
Transthyretin (TTR) amyloidosis is a form of systemic amyloidosis caused by an amyloidogenetic TTR variant. The most common mutant forms of TTR are mainly produced by the liver and therefore orthotopic liver transplantation (OLT) is currently accepted as the only known curative treatment. We describe the clinical and pathological features of a patient with TTR variant (gly53glu) with TTR amyloid infiltration of the leptomeningeal vessels in whom fatal cerebral haemorrhage occurred two months after OLT, soon after severe viral pneumonia.
AuthorsP De Carolis, M Galeotti, G Ficarra, M Masetti, D Grimaldi, P Cortelli
JournalNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (Neurol Sci) Vol. 27 Issue 5 Pg. 352-4 (Nov 2006) ISSN: 1590-1874 [Print] Italy
PMID17122946 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Prealbumin
  • Glutamic Acid
  • Glycine
Topics
  • Adult
  • Amyloidosis (genetics, surgery)
  • Cerebral Hemorrhage (etiology)
  • Glutamic Acid (genetics)
  • Glycine (genetics)
  • Humans
  • Liver Transplantation (adverse effects)
  • Male
  • Mutation
  • Prealbumin (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: